Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

USPH vs ACHC vs SEM vs SGRY

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.4%
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-14.5%
SEM
Select Medical Holdings Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$2.04B
5Y Perf.+89.2%
SGRY
Surgery Partners, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.87B
5Y Perf.+6.8%

USPH vs ACHC vs SEM vs SGRY — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
USPH logoUSPH
ACHC logoACHC
SEM logoSEM
SGRY logoSGRY
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$897M$2.25B$2.04B$1.87B
Revenue (TTM)$695M$3.37B$5.52B$3.34B
Net Income (TTM)$11M$-1.11B$134M$-76M
Gross Margin22.0%56.2%10.6%22.8%
Operating Margin12.2%11.7%5.8%11.8%
Forward P/E20.6x16.4x13.1x38.0x
Total Debt$426M$2.65B$3.70B$4.02B
Cash & Equiv.$36M$133M$27M$240M

USPH vs ACHC vs SEM vs SGRYLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

USPH
ACHC
SEM
SGRY
StockMay 20May 26Return
U.S. Physical Thera… (USPH)10079.6-20.4%
Acadia Healthcare C… (ACHC)10085.5-14.5%
Select Medical Hold… (SEM)100189.2+89.2%
Surgery Partners, I… (SGRY)100106.8+6.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: USPH vs ACHC vs SEM vs SGRY

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SEM leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. U.S. Physical Therapy, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 5 yrs, beta 0.93, yield 3.1%
  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • 16.3% revenue growth vs ACHC's 5.0%
  • 3.1% yield, 5-year raise streak, vs SEM's 1.5%, (2 stocks pay no dividend)
Best for: income & stability and growth exposure
ACHC
Acadia Healthcare Company, Inc.
The Defensive Pick

ACHC is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.84, current ratio 1.55x
Best for: sleep-well-at-night
SEM
Select Medical Holdings Corporation
The Long-Run Compounder

SEM carries the broadest edge in this set and is the clearest fit for long-term compounding and defensive.

  • 158.5% 10Y total return vs USPH's 22.6%
  • Beta 0.46, yield 1.5%, current ratio 1.04x
  • Lower P/E (13.1x vs 38.0x)
  • 2.4% margin vs ACHC's -32.8%
Best for: long-term compounding and defensive
SGRY
Surgery Partners, Inc.
The Secondary Option

SGRY lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs ACHC's 5.0%
ValueSEM logoSEMLower P/E (13.1x vs 38.0x)
Quality / MarginsSEM logoSEM2.4% margin vs ACHC's -32.8%
Stability / SafetySEM logoSEMBeta 0.46 vs SGRY's 1.04
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs SEM's 1.5%, (2 stocks pay no dividend)
Momentum (1Y)SEM logoSEM+11.1% vs SGRY's -38.2%
Efficiency (ROA)SEM logoSEM2.3% ROA vs ACHC's -18.6%, ROIC 4.8% vs 5.9%

USPH vs ACHC vs SEM vs SGRY — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B
SEMSelect Medical Holdings Corporation
FY 2025
Health Care, Patient Service, Non-Medicare
61.5%$3.4B
Health Care, Patient Service, Medicare
28.6%$1.6B
Service, Other
9.9%$538M
SGRYSurgery Partners, Inc.
FY 2025
Healthcare Organization, Patient Service
49.4%$3.2B
Private Insurance
25.8%$1.7B
Government Revenue
21.1%$1.4B
Self-Pay Revenue
1.3%$88M
Other Services
1.3%$82M
Other Patient Service Revenue Sources
1.1%$71M

USPH vs ACHC vs SEM vs SGRY — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUSPHLAGGINGSGRY

Income & Cash Flow (Last 12 Months)

USPH leads this category, winning 3 of 6 comparable metrics.

SEM is the larger business by revenue, generating $5.5B annually — 7.9x USPH's $695M. SEM is the more profitable business, keeping 2.4% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, USPH holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…
RevenueTrailing 12 months$695M$3.4B$5.5B$3.3B
EBITDAEarnings before interest/tax$107M$588M$465M$572M
Net IncomeAfter-tax profit$11M-$1.1B$134M-$76M
Free Cash FlowCash after capex$67M-$215M$117M$208M
Gross MarginGross profit ÷ Revenue+22.0%+56.2%+10.6%+22.8%
Operating MarginEBIT ÷ Revenue+12.2%+11.7%+5.8%+11.8%
Net MarginNet income ÷ Revenue+1.5%-32.8%+2.4%-2.3%
FCF MarginFCF ÷ Revenue+9.6%-6.4%+2.1%+6.2%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+7.6%+5.0%+4.5%
EPS Growth (YoY)Latest quarter vs prior year-115.0%-49.8%-18.2%+6.7%
USPH leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

SEM leads this category, winning 3 of 6 comparable metrics.

At 13.9x trailing earnings, SEM trades at a 66% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than USPH's 12.5x.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…
Market CapShares × price$897M$2.3B$2.0B$1.9B
Enterprise ValueMkt cap + debt − cash$1.3B$4.8B$5.7B$5.7B
Trailing P/EPrice ÷ TTM EPS41.55x-2.01x13.93x-23.46x
Forward P/EPrice ÷ next-FY EPS est.20.63x16.42x13.06x37.99x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple12.52x8.27x12.04x10.00x
Price / SalesMarket cap ÷ Revenue1.15x0.68x0.37x0.57x
Price / BookPrice ÷ Book value/share1.16x1.04x1.00x0.52x
Price / FCFMarket cap ÷ FCF14.71x5.33x9.57x
SEM leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

USPH leads this category, winning 5 of 8 comparable metrics.

SEM delivers a 6.6% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-41 for ACHC. USPH carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEM's 1.82x.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…
ROE (TTM)Return on equity+1.4%-40.9%+6.6%-2.2%
ROA (TTM)Return on assets+0.9%-18.6%+2.3%-0.9%
ROICReturn on invested capital+5.6%+5.9%+4.8%+4.1%
ROCEReturn on capital employed+7.6%+7.5%+7.0%+5.2%
Piotroski ScoreFundamental quality 0–95555
Debt / EquityFinancial leverage0.55x1.24x1.82x1.14x
Net DebtTotal debt minus cash$390M$2.5B$3.7B$3.8B
Cash & Equiv.Liquid assets$36M$133M$27M$240M
Total DebtShort + long-term debt$426M$2.7B$3.7B$4.0B
Interest CoverageEBIT ÷ Interest expense15.42x-5.99x4.41x1.35x
USPH leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

SEM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in SEM five years ago would be worth $8,886 today (with dividends reinvested), compared to $2,773 for SGRY. Over the past 12 months, SEM leads with a +11.1% total return vs SGRY's -38.2%. The 3-year compound annual growth rate (CAGR) favors SEM at 2.4% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…
YTD ReturnYear-to-date-24.6%+71.2%+11.4%-6.2%
1-Year ReturnPast 12 months-14.3%+1.2%+11.1%-38.2%
3-Year ReturnCumulative with dividends-43.7%-64.5%+7.4%-59.2%
5-Year ReturnCumulative with dividends-43.4%-61.8%-11.1%-72.3%
10-Year ReturnCumulative with dividends+22.6%-58.5%+158.5%-0.6%
CAGR (3Y)Annualised 3-year return-17.4%-29.2%+2.4%-25.8%
SEM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

SEM leads this category, winning 2 of 2 comparable metrics.

SEM is the less volatile stock with a 0.46 beta — it tends to amplify market swings less than SGRY's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.8% from its 52-week high vs SGRY's 59.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…
Beta (5Y)Sensitivity to S&P 5000.93x0.84x0.46x1.04x
52-Week HighHighest price in past year$93.50$30.20$16.99$24.18
52-Week LowLowest price in past year$58.55$11.43$11.65$11.41
% of 52W HighCurrent price vs 52-week peak+63.1%+81.0%+96.8%+59.2%
RSI (14)Momentum oscillator 0–10046.146.260.963.3
Avg Volume (50D)Average daily shares traded171K3.1M2.1M1.5M
SEM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

USPH leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: USPH as "Buy", ACHC as "Buy", SEM as "Hold", SGRY as "Buy". Consensus price targets imply 72.9% upside for USPH (target: $102) vs -3.9% for ACHC (target: $24). For income investors, USPH offers the higher dividend yield at 3.06% vs SEM's 1.55%.

MetricUSPH logoUSPHU.S. Physical The…ACHC logoACHCAcadia Healthcare…SEM logoSEMSelect Medical Ho…SGRY logoSGRYSurgery Partners,…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$102.00$23.50$18.00$18.60
# AnalystsCovering analysts12251322
Dividend YieldAnnual dividend ÷ price+3.1%+1.5%
Dividend StreakConsecutive years of raises5100
Dividend / ShareAnnual DPS$1.80$0.25
Buyback YieldShare repurchases ÷ mkt cap+0.6%+2.2%+4.9%0.0%
USPH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

USPH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEM leads in 3 (Valuation Metrics, Total Returns).

Best OverallU.S. Physical Therapy, Inc. (USPH)Leads 3 of 6 categories
Loading custom metrics...

USPH vs ACHC vs SEM vs SGRY: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is USPH or ACHC or SEM or SGRY a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — USPH or ACHC or SEM or SGRY?

On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.

9x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x.

03

Which is the better long-term investment — USPH or ACHC or SEM or SGRY?

Over the past 5 years, Select Medical Holdings Corporation (SEM) delivered a total return of -11.

1%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: SEM returned +158. 5% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — USPH or ACHC or SEM or SGRY?

By beta (market sensitivity over 5 years), Select Medical Holdings Corporation (SEM) is the lower-risk stock at 0.

46β versus Surgery Partners, Inc. 's 1. 04β — meaning SGRY is approximately 127% more volatile than SEM relative to the S&P 500. On balance sheet safety, U. S. Physical Therapy, Inc. (USPH) carries a lower debt/equity ratio of 55% versus 182% for Select Medical Holdings Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — USPH or ACHC or SEM or SGRY?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: Surgery Partners, Inc. grew EPS 54. 1% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — USPH or ACHC or SEM or SGRY?

Select Medical Holdings Corporation (SEM) is the more profitable company, earning 2.

7% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus 6. 1% for SEM. At the gross margin level — before operating expenses — SGRY leads at 23. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is USPH or ACHC or SEM or SGRY more undervalued right now?

On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.

1x forward P/E versus 38. 0x for Surgery Partners, Inc. — 24. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

08

Which pays a better dividend — USPH or ACHC or SEM or SGRY?

In this comparison, USPH (3.

1% yield), SEM (1. 5% yield) pay a dividend. ACHC, SGRY do not pay a meaningful dividend and should not be held primarily for income.

09

Is USPH or ACHC or SEM or SGRY better for a retirement portfolio?

For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, SGRY: -0. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between USPH and ACHC and SEM and SGRY?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: USPH is a small-cap high-growth stock; ACHC is a small-cap quality compounder stock; SEM is a small-cap deep-value stock; SGRY is a small-cap quality compounder stock. USPH, SEM pay a dividend while ACHC, SGRY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

SEM

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.6%
Run This Screen
Stocks Like

SGRY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform USPH and ACHC and SEM and SGRY on the metrics below

Revenue Growth>
%
(USPH: 7.7% · ACHC: 7.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.